Please provide your email address to receive an email when new articles are posted on . The FDA announced it designated a recall of intra-aortic balloon pumps due to problems related to fluid leak as ...
Please provide your email address to receive an email when new articles are posted on . Arrow International announced it is recalling its intra-aortic balloon pumps after receiving complaints about ...
Getinge is recalling 4,338 intra-aortic balloon pumps after discovering fluid leaks that can lead to unexpected shutdowns or the inability to initiate therapy, the FDA said Dec. 16. The agency has ...
The Cardiosave Hybrid and Cardiosave Rescue intra-aortic balloon pumps (IABPs) have been hit with another recall by the manufacturer (Getinge/Datascope), this time due to damage to the balloon ...
Getinge heart balloon pumps further deflated by 4 more Class I recalls and 6 reported patient deaths
In a flurry of Aug. 31 notices from the FDA, the number of Class I recalls plaguing Getinge’s Cardiosave intra-aortic balloon pumps this year has doubled. The notices detailed four more recalls of the ...
IABP systems are typically inserted within the multidisciplinary environment that is the cardiac catheterization laboratory. The specific role of the physiologist during IABP insertion is to ensure ...
Getinge subsidiary Datascope has recalled thousands of Intra-Aortic Balloon Pumps in 2023, and in the latest notice, the FDA labeled the issue as Class I because of unexpected shutdowns. On Aug. 10, ...
Only a month after Getinge announced the suspension of the CE marks allowing it to sell its heart-lung support and permanent life support systems in Europe, the Swedish devicemaker has temporarily ...
Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results